Table 3.
Maternal SNP | Fetal SNP | Interaction ORa | 95% CIb | p-value | q-valuec | LRT p-value from step 2d,e |
---|---|---|---|---|---|---|
ENPP1 rs1044498 | SLC2A2 rs6785233 | 3.65 | 2.32–5.74 | 2.09E-08 | 0.001 | 0.00004 |
LEP rs12706831 | SLC2A2 rs6785233 | 0.45 | 0.29–0.71 | 0.0005 | 0.016 | 0.00001 |
ENPP1 rs1044498 | SLC2A2 rs5400 | 1.98 | 1.34–2.92 | 0.0006 | 0.016 | 0.001 |
LEP rs2071045 | SLC2A2 rs5400 | 0.50 | 0.32–0.77 | 0.0016 | 0.03 | 0.008 |
LEP rs2071045 | SLC2A2 rs6785233 | 0.46 | 0.27–0.77 | 0.0029 | 0.04 | 0.06 |
LEP rs12706831 | SLC2A2 rs5400 | 0.59 | 0.41–0.86 | 0.0059 | 0.08 | NE |
LEP rs11760956 | SLC2A2 rs6785233 | 0.63 | 0.41–0.99 | 0.0450 | 0.44 | NE |
LEP rs3828942 | SLC2A2 rs6785233 | 0.64 | 0.42–0.99 | 0.0473 | 0.44 | NE |
Interaction odds ratio (OR) from step 1 (case-only analysis)
Confidence interval (CI)
False discovery rate q-value
Only interactions where q<0.05 in step 1 were confirmed in step 2 (log-linear analysis in case-parent triads)
Not estimated (NE)